Sep 24, 2026 08:01AM
Sep 24, 2026 08:00AM
Aug 13, 2026 02:45AM
Aug 12, 2026 06:05AM
Aug 12, 2026 06:00AM
Aug 12, 2026 06:00AM
Aug 6, 2026 04:16PM Goldman Sachs Reiterates Neutral Rating on Annexon Biosciences (ANNX)
Aug 6, 2026 08:04AM
Aug 6, 2026 08:00AM
Jul 30, 2026 04:01PM
Jul 30, 2026 04:01PM
Jul 14, 2026 04:05PM
Jul 14, 2026 04:05PM
May 7, 2026 04:01PM Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones
Mar 30, 2026 04:01PM
Feb 17, 2026 08:00AM
Jan 12, 2026 07:08AM
Jan 12, 2026 07:00AM
Jan 8, 2026 08:00AM
Dec 1, 2025 04:17PM
Nov 10, 2025 04:05PM Annexon Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Aug 14, 2025 04:05PM
Aug 7, 2025 04:31PM
Aug 7, 2025 04:30PM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM
Jun 18, 2025 04:05PM
May 19, 2025 04:07PM Annexon (ANNX) Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS)
May 19, 2025 04:05PM
May 12, 2025 08:00AM
May 9, 2025 05:00PM
May 7, 2025 08:00AM
Apr 9, 2025 07:00AM
Apr 8, 2025 04:05PM
Apr 3, 2025 06:18PM Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
Mar 3, 2025 08:00AM
Feb 13, 2025 08:30AM
Dec 17, 2024 06:53AM
Dec 16, 2024 07:31AM
Dec 16, 2024 07:30AM
Dec 5, 2024 08:00AM
Nov 14, 2024 08:00AM Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
Oct 21, 2024 08:00PM
Oct 15, 2024 08:02AM
Oct 15, 2024 08:00AM
Sep 9, 2024 08:00AM
Aug 13, 2024 09:28AM
Aug 12, 2024 08:00AM
Aug 5, 2024 08:00AM Annexon Provides Update on ARCHER II Global Registrational Program in Geographic Atrophy
Jul 11, 2024 06:09PM

334,267 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All